Related Experiment Video
Updated: Jun 1, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
[Treatment strategies for pediatric patients with primary cardiac tumors]
Li-sheng Qiu1, Yan-juan Sun, Wen-xiang Ding
1Department of Cardiothoracic Surgery, Shanghai Children's Medical Center, Shanghai Jiaotong University, Shanghai 200127, China.
Insights
Treatment strategies for pediatric primary cardiac tumors vary. Surgery is recommended for symptomatic cases, while asymptomatic patients require close monitoring. Restoring normal heart function is the primary goal, not just complete tumor removal.
Area of Science:
- Pediatric Cardiology
- Cardiac Oncology
- Pediatric Surgery
Context:
- Primary cardiac tumors are rare in children, often presenting with significant symptoms.
- Echocardiography is crucial for diagnosis and monitoring.
- A majority of diagnosed pediatric cardiac tumors occur in infants under one year old.
Purpose:
- To analyze treatment strategies for pediatric primary cardiac tumors.
- To evaluate the outcomes of surgical and non-surgical interventions.
- To determine the factors influencing morbidity and mortality in this population.
Summary:
- This retrospective study analyzed 27 pediatric patients with primary cardiac tumors, with 22 undergoing surgery. Histologies included rhabdomyomas, fibromas, hemangiomas, myxomas, and sarcomas.
- Surgical outcomes varied, with complete resection in 14 patients and partial in 8. Postoperative complications included low cardiac output and arrhythmias, with 4 in-hospital deaths.
- Follow-up revealed tumor regression in some cases (rhabdomyomas) and stability in others (fibrosarcoma, hemangioma), with no recurrence of myxomas.
Impact:
- Individualized therapy is essential for pediatric primary cardiac tumors.
- Surgery is indicated for symptomatic patients, prioritizing hemodynamic restoration over complete resection alone.
- Close follow-up is crucial for all patients, regardless of initial treatment, to manage potential complications and monitor tumor status.
Objective:
To analyze the experience of treatment strategies for pediatric patients with primary cardiac tumors.
Methods:
The clinical data of 27 patients with primary cardiac tumors which detected by echocardiography from May 1999 to May 2009 was analyzed retrospectively. There were 20 male and 7 female patients, aged from 24 d to 12.6 years. There were 59.2% less than 1 year old at the time of diagnosis. A single tumor were present in 22 cases and multiple in 5 cases. Surgery was performed for 22 patients due to the varied significant symptoms such as arrhythmia, pericardial effusion, swoon and congestive heart failure with dyspnoea. Five patients were discharged hospital without surgical treatment. The surgical approaches were adopted according to tumor location. Complete surgical resection was performed in 14 patients and partial resection in 8 patients. Seven patients were underwent valve reconstruction, 5 involving the mitral valve and 2 involving the tricuspid valve.
Results:
Histologic examination of the surgically resected tumors showed rhabdomyomas in 8 cases, fibromas in 5 cases, hemangiomas 3 cases, myxomas in 4 cases, fibrosarcoma in 1 case and yolk sac sarcoma in 1 case. Sixteen cases revealed stable haemodynamic status postoperative. Two cases occurred apparent symptoms of low cardiac output and significant arrhythmias, finally recovery after comprehensive treatment of restoration the heart function. There was a total of 4 patients in-hospital death following surgery due to multiorgan system failure. Of the 18 patients who survived after the surgery were followed up from 1 to 10 years, echocardiography showed the residual mass of the tumor with partial resection, rhabdomyoma diminishing in 2 patients and almost vanishing in 1 patient. The residual mass of one fibrosarcoma patient and one hemangioma patient were not increased. Patients with myxomas had no recur or systemic embolisation after the initial surgery. Five nonsurgical patients were followed up from 1 to 3 years, 2 patients without haemodynamic alterations, 1 patients with giant tumor of left ventricular free wall was died of arrhythmia, the other one was alive; the patient of multiple cardiac tumor with low cardiac output was died of heart failure.
Conclusions:
Despite the benign histology of most paediatric primary cardiac tumours, there may be significant associated with morbidity and occasional mortality. Therapy strategies should be individualised: surgery is indicated in cases with significant clinical symptoms and close follow-up is necessary for asymptomatic patients. Total resection is not the only therapeutic aim. Most important is the restoration of the normal haemodynamic heart function.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
Heart Failure VI: Adjunct Therapies
Mitral Stenosis III: Medical Management
Myocarditis III: Medical Management
